HIV prevention: better choice for better coverage.

ABSTRACT:

Introduction

Antiretroviral-based pre-exposure prophylaxis (PrEP) is today an established, effective and safe method of HIV prevention used in multiple countries worldwide by a broad range of populations at risk of HIV infection. Biomedical innovations are critical in supporting the primary prevention of HIV; however, their potential can only be maximized if end-user challenges are recognized, described and used to develop next-generation models.

Discussion

First-generation PrEP, a daily oral pill, is highly efficacious, discreet and affords users the ability to commence and conclude treatment rapidly. However, consistent daily adherence and persistence is challenging, especially among younger populations, due in part to side effects, the risk of stock-outs and a lack of pil

SUBMITTER: Bekker LG 

PROVIDER: S-EPMC8759757 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature